Metabolic syndrome-related conditions among people with and without gout: Prevalence and resource use

Current Medical Research and Opinion

Volumn 23, Issue 3, 2007, Pages 623-630

  Novak, Suzanne ^a   Melkonian, Arthur K ^b   Patel, Pankaj A ^c   Kleinman, Nathan L ^d   Joseph Ridge, Nancy ^c   Brook, Richard A ^e,f  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Human Capital Management Services   (Armenia)

^c TAP PHARMACEUTICAL PRODUCTS INC   (United States)

^d Human Capital Management Services   (United States)

^e JeSTARx Group   (United States)

^f Retrospective Analysis   (United States)

Author keywords

Epidemiology; Gout; Hyperuricemia; Metabolic syndrome

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; GOUT; HEALTH CARE COST; HEALTH SERVICE; HUMAN; HYPERLIPIDEMIA; MALE; METABOLIC SYNDROME X; MORTALITY; PREVALENCE;

ADULT; AGE DISTRIBUTION; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; EMPLOYMENT; FEMALE; GOUT; HEALTH SURVEYS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SICK LEAVE; UNITED STATES;

EID: 33947356988     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X167651     Document Type: Article

References (39)

1. Wallace KL, Riedel AA, Joseph-Ridge N, et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004;31:1582-7
2. Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 2006;8:S2 [Epub ahead of print 12 Apr 2006]
3. Suresh E. Diagnosis and management of gout: a rational approach. Postgrad Med J 2005;81:572-9
4. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987;82:421-6
5. Luk AJ, Simkin PA. Epidemiology of hyperuricemia and gout. Am J Manag Care 2005;11:S435-42
6. Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002;40:37-42
7. Choi HK, Atkinson K, Karlson EW, et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005;165:742-8
8. Modan M, Halkin H, Karasik A, et al. Elevated serum uric acid - a facet of hyperinsulinaemia. Diabetologia 1987;30:713-8
9. Chou P, Li CL, Wu GS, et al. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes. Diabetes Care 1998;21:1183-7
10. Lin KC, Tsai ST, Lin HY, et al. Different progressions of hyperglycemia and diabetes among hyperuricemic men and women in the Kinmen study. J Rheumatol 2004;31:1159-65
11. Nakanishi N, Okamoto M, Yoshida H, et al. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003;18:523-30
12. Jossa F, Farinaro E, Panico S et al. Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens 1994;8:677-81
13. Masuo K, Kawaguchi H, Mikami H, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003;42:474-80
14. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003;42:247-52
15. Rathmann W, Funkhouser E, Dyer AR, et al. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 1998;8:250-61
16. Johnson RJ, Segal MS, Srinivas T, et al. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J Am Soc Nephrol 2005;16:1909-19
17. Choi HK, Curhan G. Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol 2005;17:341-5
18. Vazquez-Mellado J, Alvarez Hernandez E, Burgos-Vargas R. Primary prevention in rheumatology: the importance of hyperuricemia. Best Pract Res Clin Rheumatol 2004;18:111-24
19. Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004;50:2400-14
20. Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol 2002;29:1350-5
21. Emmerson B. Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis 1998;57:509-10
22. Solymoss BC, Marcil M, Chaour M, et al. Fasting hyperinsulinism, insulin resistance syndrome, and coronary artery disease in men and women. Am J Cardiol 1995;76:1152-6
23. American Heart Association; National Heart, Lung, and Blood Institute; Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 2005;13:322-7
24. Grundy SM, Hansen B, Smith SC Jr, et al. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol 2004;24:el9-24
25. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-4
26. Shah S, Novak S, Stapleton LM. Evaluation and comparison of models of metabolic syndrome using confirmatory factor analysis. Eur J Epidemiol 2006;21:343-9
27. Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:1546-51
28. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404-10
29. Baker JF, Krishnan E, Chen L, et al. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005;118:816-26
30. Krishnan E, Baker JF, Furst DE, et al. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006;54:2688-96
31. Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002;105:2619-24
32. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003;107:1991-7
33. Riedel AA, Nelson M, Wallace K, et al. Prevalence of comorbid conditions and prescription medication use among patients with gout and hyperuricemia in a managed care setting. J Clin Rheumatol 2004;10:308-14
34. Elixhauser A, Steiner C, Palmer L. Clinical Classifications Software, 2004. U.S. Agency for Healthcare and Research. Available from http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp [Last accessed November 4, 2004]
35. Kraja AT, Borecki IB, North K, et al. Longitudinal and age trends of metabolic syndrome and its risk factors: The Family Heart Study. Nutr Metab (Lond) 2006;3:41
36. Freedman DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995;141:637-44
37. Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000;36:1072-8
38. Becker MA, Jolly M. Hyperuricemia and associated diseases. Rheum Dis Clin North Am 2006;32:275-93
39. Rao JK, Callahan LF, Helmick CG 3rd. Characteristics of persons with self-reported arthritis and other rheumatic conditions who do not see a doctor. J Rheumatol 1997;24:169-73